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Abstract: Infectious complications are common adverse events of solid organ transplantation and im-
munosuppressive therapy. In the perioperative setting, most infections are of bacterial or viral origin.
Risk assessment of donor and recipient focuses mostly on blood-borne pathogens. Occasionally, parasitic
infections are reported after transplantation. In regard to the latter, we report the case of a 57-year-old
patient who underwent simultaneous pancreas-kidney transplantation and shortly thereafter developed
diarrhea, abdominal bloating and weight loss due to Giardia duodenalis.
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Infectious complications are common adverse events of solid organ transplantation and immunosuppressive
therapy. In the perioperative setting, most infections are of bacterial or viral origin. Risk assessment of donor
and recipient focuses mostly on blood-borne pathogens. Occasionally, parasitic infections are reported after
transplantation. In regard to the latter, we report the case of a 57-year-old patient who underwent simultaneous
pancreas-kidney transplantation and shortly thereafter developed diarrhea, abdominal bloating and weight loss
due to Giardia duodenalis.
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A 57-year-old caucasian male from Switzerland with long-standing
type I diabetes mellitus (T1DM) and end-stage renal disease (ESRD)
underwent simultaneous pancreas-kidney transplantation (SPKT)
from a deceased brain stem dead donor. Prior medical history included
autonomous neuropathy with orthostatic dysregulation, coronary and
peripheral artery disease aswell as severe secondary hyperparathyroid-
ism. He had not traveled abroad in the year before transplantation.
The donor was a 50-year-old man, who had suffered brain death
from an intracerebral bleeding due to arteriovenous malformation. In
the patient history, abdominal disease was not reported. The pancreatic
graft was transplanted after standard backtable preparation, involving
removal of the donor spleen, shortening of the duodenum, sewing
over of the mesentery and arterial reconstruction with a “y”-graft
using the donor's iliac bifurcation. The duodenal segment of the graft
was anastomosed to the second jejunal loop and the portal vein to the
vena cava. The donor kidney was implanted into the left iliac fossa.
The patient had full function of both grafts with immediate insulin-
independency and without dialysis requirement. Immunosuppressive
therapy consisted of tacrolimus, mycophenolic acid (MPA) and predni-
sone. Due to induction treatment with thymoglobulin and an interme-
diate risk for cytomegalovirus (CMV) reactivation valganciclovir
prophylaxis was started. During the hospital stay, a standard two
week course of anti-infective therapy with piperacillin/tazobactam
and fluconazole was administered. At discharge, themedication also in-
cluded trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pro-
phylaxis, standard-dose proton pump inhibitor and vitamin D.
Fourweeks after transplantation, the patient presented to the emer-
gency department with malaise, new-onset of abdominal bloating and
diarrhea. Physical examination demonstrated signs of dehydration. His
body-weight had dropped by 6.5 kg since discharge. Blood chemistry
showed worsening of kidney allograft function with an 1.6 increase in
serum creatinine, as well as a hypoosmolar hyponatremia. Tacrolimus
trough level was elevated at 20.6 μg/l. Urine sediment was unremark-
able except for sparse hyaline casts. Primarily prerenal acute kidney in-
jury due to severe diarrhea with possibly additional calcineurin-
inhibitor (CNI) toxicity was concluded. After fluid resuscitation, graft
function as well as the hyponatremia recovered well. Tacrolimus was
adapted until trough levels were within target range.
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To unravel the cause of diarrhea, upper and lower endoscopy were
performed one week after admission. Macroscopic finding was unre-
markable. Histopathology, however, demonstrated many trophocytes
restricted to the donor duodenal segment (Image 1), while the recipient
duodenum showed no alterations (Image 2). No MPA- or CMV-
associated injury was observed in the colonic biopsies. Stool screening
was negative for Clostridium difficile.
In conclusion, the diagnosis of transplant-acquired giardiasis was
established. To avoid drug interactions with MPA and tacrolimus, anti-
parasitic treatment with ornidazole 1.5 g OD for 2 days was chosen
over metronidazole. Hereafter, diarrhea resolved quickly, kidney graft
function remained stable and hyponatremia did not recur. The patient
remained insulin independent throughout the course.
Conclusion
Organ transplantation is often the only therapeutic option to prolong
survival in the setting of end-stage organ failure. For T1DMwith ESRD,
SPKT is preferred over kidney transplantation alone, because it im-
proves quality of life and is believed to reduce long-term macro- and
microvascular complications of diabetes, therefore leading to an im-
proved kidney allograft survival [11]. While preventing acute rejection,
immunosuppressive therapy also places the patient at risk for infec-
tions. In kidney transplantation, infections are often associated with
worsening graft function and increased morbidity and mortality [3,6].
Most infections in the early post-transplantation period are due to
blood-borne viruses (i.e. Cytomegalovirus/Epstein–Barr Virus/BK-
Virus) or bacterial pathogens; only few are of parasitic nature [2]. Pre-
transplant infectious disease screening assesses the presence of the
most common blood-borne pathogens in the donor, as well as previous
exposure and immunity of the recipient. With the exception of toxo-
plasmosis, organ donors are not routinely screened for parasites in
most countries [12]. However, due to immunosuppression, recipients
are more susceptible to parasitic infections and, depending on the geo-
graphical region, might even be at risk of infection with multiple para-
sites [1].
Worldwide, Giardia duodenalis is one of the most common parasites
causing diarrhea [5]. The prevalence in humans differs depending on
the region between 2% and 30% in industrialized and developing coun-
tries, respectively [5,9]. With continuously rising numbers of solid-
organ transplantation, especially in endemic countries, the number of
publications on post-transplant parasitic infections, including Giardia-
sis, also increases [8,14–16]. Another contributing factor could be the
ever-increasing migratory population in our globalized world. In 2006,
10% of all transplanted organs in Spain were from foreign donors,
while 3% were foreign recipients. In addition, 40% of foreign donors or
recipients in Spain were from Latin America, potentially endemic
areas [13]. Male sex, possibly due to MSM, is also associated with an in-
creased risk for Giardiasis [7]. Finally, potentially overlooked infectious
carriers are pets with worldwide pooled prevalence rates of 15.2% and
12% for dogs and cats [4].
SPKT represents a unique circumstance, as transplantation of the du-
odenum exposes the recipient to the additional risk of infection with
intraluminal pathogens, likeGiardia spp. However, as SPKT is performed
only in selected patients, post-transplantation Giardiasis is a rare occur-
rence. In the early setting after SPKT, only one other case has been re-
ported by Kristensen and colleagues [10]. Several factors set our case
apart. The donor of our patient did not originate from an endemic re-
gion, e.g. Middle East. He was a Swiss national with a seemingly unre-
markable travel history. Secondly, in our case, the rapid development
of symptoms and early histopathologic diagnosis clearly unmasks the
transplantation as themodality of infection. Biopsies demonstrated tro-
phozoites only in the donor and not recipient duodenum, making the
reactivation of a latent infection unlikely.
The question that arises is whether pre-transplantation infectious dis-
ease screening should include testing for Giardia spp., especially before
SPKT. For parasites like Trypanosoma cruzi and Strongyloides stercoralis,
the American Society of Transplantation Infectious Diseases Community
of Practice recommends screening of donors from endemic regions, due
to their significant prevalence in those areas and the associatedmorbidity
with peri-transplant infection [12]. Regarding Giardiasis, however, the lit-
erature is sparse and consists mainly of case reports. For European pa-
tients, travel to tropical countries appears to be the main risk factor for
post-transplant parasitic infections, including Giardiasis [16].
In conclusion, parasitic infections – like Giardiasis – are rare compli-
cations in the early post-transplant setting, but carry the risk for signif-
icantmorbidity. As this case shows, they should be considered even in a
scenario, where donor and recipient are not from endemic regions. Cur-
rently, empirical screening cannot be advised. However, early recogni-
tion and stool antigen testing could prevent invasive diagnostic
procedures like endoscopy.
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